Joseph C Chao, MD
Cardiovascular Disease (Cardiology) · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chao’s office at (650) 962-0242 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A45961 · Current
Licensed to practise in California · since 1989 · expires 2028-08-31 · National Taiwan University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$148,320
Medicare paid this office $148,320 for 209 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of both sides of head and neck blood flow | 186 | $46,743 | $185 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 184 | $38,406 | $151 |
| Return visit (30+ min) | 193 | $36,652 | $105 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 74 | $17,899 | $218 |
| New patient visit (45+ min) | 41 | $5,260 | $128 |
See all 6 services
| Ultrasound of both sides of head and neck blood flow | 186 | $46,743 | $185 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 184 | $38,406 | $151 |
| Return visit (30+ min) | 193 | $36,652 | $105 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 74 | $17,899 | $218 |
| New patient visit (45+ min) | 41 | $5,260 | $128 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 187 | $2,805 | $11 |
Who their Medicare patients are
209 Original Medicare patients in 2024. Average age 75 · Under 65 0% · 85 and older 9% · Women 42% · Also on Medicaid 9% · Health risk score 0.71. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 68% · Coronary heart disease 47% · Diabetes 30% · Atrial fibrillation 19% · Stroke 19% · Chronic kidney disease 13% · Cancer 8% · COPD 5%.
The office billed $321,375, Medicare allowed $196,018 and paid $148,320; for 1,266 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 209 | 1,266 | 75 | 0.71 | $321,375 | $148,320 |
| 2023 | 265 | 1,860 | 75 | 0.74 | $475,595 | $240,927 |
| 2022 | 273 | 2,848 | 75 | 0.75 | $713,555 | $379,126 |
| 2021 | 229 | 2,282 | 75 | 0.75 | $618,380 | $305,633 |
| 2020 | 186 | 1,807 | 76 | 0.83 | $548,860 | $226,569 |
| 2019 | 225 | 2,237 | 75 | 0.82 | $692,340 | $281,548 |
| 2018 | 214 | 2,202 | 75 | 0.85 | $676,770 | $272,761 |
| 2017 | 199 | 2,006 | 75 | 0.90 | $611,640 | $244,418 |
| 2016 | 177 | 1,959 | 75 | 0.85 | $595,691 | $242,763 |
| 2015 | 184 | 1,896 | 76 | 0.90 | $572,793 | $236,604 |
| 2014 | 197 | 1,882 | 75 | 1.09 | $580,980 | $244,310 |
| 2013 | 200 | 2,187 | 76 | 1.02 | $643,635 | $255,112 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Ultrasound of both sides of head and neck blood flow | 248 | $71,542 | $205 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 246 | $56,948 | $165 |
| Return visit (30+ min) | 245 | $55,350 | $110 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 128 | $33,219 | $241 |
| New patient visit (45+ min) | 63 | $9,320 | $148 |
| Complete ultrasound scan of abdomen | 72 | $8,883 | $123 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 248 | $4,029 | $11 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $858 | $66 |
2022: 10 services
| Ultrasound of both sides of head and neck blood flow | 271 | $91,833 | $209 |
| Return visit (30+ min) | 255 | $81,368 | $117 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 270 | $75,757 | $172 |
| Complete ultrasound scan of abdomen | 270 | $55,183 | $126 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 163 | $45,714 | $243 |
| New patient visit (45+ min) | 91 | $13,455 | $148 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 270 | $5,551 | $12 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 32 | $3,159 | $72 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 12 | $294 | $24 |
| Heart rhythm recording of continous external ekg over 8-15 days | 15 | $209 | $13 |
2021: 8 services
| Ultrasound of both sides of head and neck blood flow | 223 | $76,051 | $217 |
| Return visit (30+ min) | 219 | $67,533 | $116 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 226 | $62,879 | $177 |
| Complete ultrasound scan of abdomen | 227 | $45,713 | $129 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 121 | $33,958 | $252 |
| New patient visit (45+ min) | 53 | $7,578 | $143 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 227 | $4,968 | $12 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $2,106 | $75 |
2020: 8 services
| Ultrasound of both sides of head and neck blood flow | 175 | $56,040 | $213 |
| Return visit (30+ min) | 175 | $46,977 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 177 | $46,323 | $176 |
| Complete ultrasound scan of abdomen | 177 | $33,854 | $128 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 106 | $28,551 | $242 |
| New patient visit (45+ min) | 52 | $7,100 | $137 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 175 | $4,239 | $14 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $2,807 | $80 |
2019: 8 services
| Ultrasound of both sides of head and neck blood flow | 217 | $70,740 | $210 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 219 | $58,964 | $174 |
| Return visit (30+ min) | 209 | $56,845 | $98 |
| Complete ultrasound scan of abdomen | 216 | $41,507 | $124 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 102 | $25,193 | $235 |
| New patient visit (45+ min) | 69 | $9,584 | $139 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 217 | $5,609 | $14 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $3,672 | $82 |
2018: 8 services
| Ultrasound of both sides of head and neck blood flow | 206 | $70,456 | $210 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 207 | $59,221 | $175 |
| Return visit (30+ min) | 202 | $54,302 | $95 |
| Complete ultrasound scan of abdomen | 206 | $42,021 | $125 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 91 | $24,148 | $234 |
| New patient visit (45+ min) | 62 | $8,193 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 210 | $5,430 | $14 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 30 | $3,539 | $84 |
2017: 8 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 194 | $68,620 | $221 |
| Return visit (30+ min) | 186 | $49,048 | $92 |
| Ultrasound of both sides of head and neck blood flow | 193 | $48,984 | $159 |
| Complete ultrasound scan of abdomen | 191 | $36,604 | $119 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 92 | $24,720 | $260 |
| New patient visit (45+ min) | 56 | $7,613 | $136 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 194 | $4,756 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 28 | $2,850 | $79 |
2016: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 174 | $62,342 | $224 |
| Return visit (30+ min) | 168 | $48,036 | $93 |
| Ultrasound of both sides of head and neck blood flow | 173 | $44,633 | $162 |
| Complete ultrasound scan of abdomen | 172 | $33,421 | $121 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 104 | $30,174 | $262 |
| New patient visit (45+ min) | 49 | $6,728 | $137 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 37 | $5,061 | $80 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 175 | $4,796 | $14 |
| Short return visit (20+ min) | 13 | $1,175 | $65 |
2015: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 181 | $64,552 | $230 |
| Ultrasound of both sides of head and neck blood flow | 181 | $45,959 | $164 |
| Return visit (30+ min) | 171 | $43,818 | $95 |
| Complete ultrasound scan of abdomen | 180 | $34,091 | $123 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 83 | $25,913 | $273 |
| New patient visit (45+ min) | 45 | $6,354 | $141 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 180 | $4,881 | $14 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 33 | $4,043 | $83 |
| Short return visit (20+ min) | 31 | $2,746 | $65 |
2014: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 188 | $64,383 | $228 |
| Ultrasound of both sides of head and neck blood flow | 188 | $42,587 | $153 |
| Return visit (30+ min) | 174 | $39,769 | $95 |
| Complete ultrasound scan of abdomen | 186 | $39,315 | $141 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 96 | $30,080 | $281 |
| New patient visit (45+ min) | 65 | $9,614 | $148 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 193 | $4,449 | $14 |
| Short return visit (20+ min) | 43 | $4,433 | $65 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $3,084 | $83 |
2013: 9 services
| Ultrasound of both sides of head and neck blood flow | 196 | $53,263 | $188 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 197 | $43,921 | $155 |
| Complete ultrasound scan of abdomen | 196 | $39,083 | $139 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 118 | $32,226 | $232 |
| Return visit (30+ min) | 156 | $32,148 | $96 |
| Short return visit (20+ min) | 100 | $18,635 | $66 |
| New patient visit (45+ min) | 93 | $13,421 | $144 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 62 | $7,601 | $84 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 197 | $5,626 | $15 |
Drugs they prescribed that Part D paid
$135,007
Pharmacies billed $135,007 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 697) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
582 generic and 115 brand-name prescriptions · $135,007 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 30 | $36,400 | $1,213 |
| Xarelto | 22 | $29,911 | $1,360 |
| Rosuvastatin | 244 | $2,449 | $10 |
| Propafenone Hcl Er | 11 | $2,159 | $196 |
| Flecainide Acetate | 16 | $736 | $46 |
See all 14 drugs
| Eliquis | 30 | $36,400 | $1,213 |
| Xarelto | 22 | $29,911 | $1,360 |
| Rosuvastatin | 244 | $2,449 | $10 |
| Propafenone Hcl Er | 11 | $2,159 | $196 |
| Flecainide Acetate | 16 | $736 | $46 |
| Metoprolol | 47 | $573 | $12 |
| Atorvastatin | 32 | $326 | $10 |
| Metformin | 30 | $306 | $10 |
| Levothyroxine | 23 | $262 | $11 |
| Pravastatin | 11 | $212 | $19 |
| Clopidogrel | 23 | $184 | $8 |
| Losartan | 20 | $95 | $5 |
| Amlodipine Besylate | 13 | $90 | $7 |
| Atenolol | 24 | $88 | $4 |
Year by year
| 2024 | 697 | 144 | 0% (0) | 16% | $135,007 |
| 2023 | 682 | 120 | 0% (0) | None | $115,433 |
| 2022 | 636 | 125 | 0% (0) | None | $114,108 |
| 2021 | 572 | 116 | 0% (0) | 24% | $115,482 |
| 2020 | 618 | 115 | 0% (0) | 34% | $155,234 |
| 2019 | 687 | 115 | 0% (0) | 33% | $154,538 |
| 2018 | 673 | 120 | 0% (0) | 36% | $138,580 |
| 2017 | 582 | 104 | 0% (0) | 39% | $94,384 |
| 2016 | 514 | 99 | 0% (0) | 44% | $91,360 |
| 2015 | 459 | 94 | 0% (0) | 40% | $72,398 |
| 2014 | 510 | 94 | 0% (0) | 46% | $83,784 |
| 2013 | 630 | 105 | 0% (0) | 46% | $95,358 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Xarelto | 21 | $30,443 | $1,450 |
| Eliquis | 28 | $25,060 | $895 |
| Entresto | 14 | $13,015 | $930 |
| Praluent | 17 | $11,007 | $647 |
| Propafenone Hcl Er | 22 | $9,840 | $447 |
| Rosuvastatin | 207 | $3,548 | $17 |
| Metoprolol | 58 | $1,150 | $20 |
| Flecainide Acetate | 16 | $1,096 | $69 |
| Clopidogrel | 34 | $529 | $16 |
| Metformin | 31 | $332 | $11 |
| Atorvastatin | 46 | $316 | $7 |
| Levothyroxine | 24 | $286 | $12 |
| Losartan | 18 | $131 | $7 |
| Amlodipine Besylate | 15 | $126 | $8 |
| Atenolol | 20 | $118 | $6 |
2022: 16 drugs
| Xarelto | 35 | $41,644 | $1,190 |
| Eliquis | 25 | $18,426 | $737 |
| Entresto | 18 | $13,427 | $746 |
| Propafenone Hcl Er | 14 | $9,926 | $709 |
| Praluent | 11 | $7,539 | $685 |
| Brilinta | 11 | $5,008 | $455 |
| Rosuvastatin | 176 | $4,662 | $26 |
| Flecainide Acetate | 29 | $1,706 | $59 |
| Metoprolol | 52 | $1,026 | $20 |
| Clopidogrel | 29 | $565 | $19 |
| Atorvastatin | 62 | $461 | $7 |
| Levothyroxine | 22 | $276 | $13 |
| Metformin | 22 | $103 | $5 |
| Losartan | 15 | $101 | $7 |
| Atenolol | 16 | $33 | $2 |
| Amlodipine Besylate | 13 | $22 | $2 |
2021: 12 drugs
| Xarelto | 48 | $52,184 | $1,087 |
| Eliquis | 16 | $12,482 | $780 |
| Entresto | 18 | $12,341 | $686 |
| Rosuvastatin | 151 | $5,536 | $37 |
| Flecainide Acetate | 21 | $1,475 | $70 |
| Atorvastatin | 63 | $869 | $14 |
| Metoprolol | 41 | $772 | $19 |
| Clopidogrel | 26 | $556 | $21 |
| Levothyroxine | 23 | $469 | $20 |
| Losartan | 17 | $167 | $10 |
| Metformin | 27 | $109 | $4 |
| Atenolol | 12 | $12 | $1 |
2020: 13 drugs
| Xarelto | 63 | $56,318 | $894 |
| Entresto | 36 | $24,481 | $680 |
| Eliquis | 34 | $21,498 | $632 |
| Propafenone Hcl Er | 11 | $8,847 | $804 |
| Praluent | 13 | $7,267 | $559 |
| Rosuvastatin | 136 | $6,999 | $51 |
| Edarbyclor | 12 | $3,811 | $318 |
| Flecainide Acetate | 24 | $1,268 | $53 |
| Metoprolol | 36 | $870 | $24 |
| Atorvastatin | 46 | $866 | $19 |
| Clopidogrel | 28 | $782 | $28 |
| Levothyroxine | 24 | $664 | $28 |
| Metformin | 19 | $120 | $6 |
2019: 16 drugs
| Xarelto | 74 | $46,457 | $628 |
| Entresto | 45 | $33,088 | $735 |
| Eliquis | 34 | $20,875 | $614 |
| Propafenone Hcl Er | 13 | $9,229 | $710 |
| Rosuvastatin | 111 | $8,104 | $73 |
| Edarbyclor | 20 | $5,668 | $283 |
| Flecainide Acetate | 39 | $1,556 | $40 |
| Atorvastatin | 74 | $1,398 | $19 |
| Metoprolol | 37 | $1,237 | $33 |
| Clopidogrel | 32 | $1,057 | $33 |
| Levothyroxine | 14 | $426 | $30 |
| Fenofibrate | 11 | $393 | $36 |
| Ezetimibe | 12 | $312 | $26 |
| Losartan | 26 | $268 | $10 |
| Metformin | 16 | $143 | $9 |
| Atenolol | 16 | $59 | $4 |
2018: 16 drugs
| Xarelto | 67 | $32,233 | $481 |
| Entresto | 44 | $28,941 | $658 |
| Eliquis | 32 | $17,835 | $557 |
| Praluent | 11 | $12,491 | $1,136 |
| Propafenone Hcl Er | 11 | $9,332 | $848 |
| Edarbyclor | 34 | $8,290 | $244 |
| Savaysa | 17 | $6,032 | $355 |
| Rosuvastatin | 86 | $4,702 | $55 |
| Atorvastatin | 101 | $2,304 | $23 |
| Metoprolol | 43 | $1,650 | $38 |
| Flecainide Acetate | 17 | $772 | $45 |
| Clopidogrel | 27 | $654 | $24 |
| Olmesartan-Hydrochlorothiazide | 12 | $502 | $42 |
| Losartan | 27 | $377 | $14 |
| Losartan-Hydrochlorothiazide | 12 | $183 | $15 |
| Metformin | 11 | $128 | $12 |
2017: 17 drugs
| Xarelto | 36 | $14,671 | $408 |
| Eliquis | 22 | $13,181 | $599 |
| Entresto | 28 | $11,443 | $409 |
| Benicar Hct | 18 | $7,973 | $443 |
| Savaysa | 18 | $5,688 | $316 |
| Rosuvastatin | 68 | $5,027 | $74 |
| Edarbyclor | 21 | $4,044 | $193 |
| Atorvastatin | 104 | $2,015 | $19 |
| Flecainide Acetate | 18 | $1,799 | $100 |
| Metoprolol | 40 | $1,558 | $39 |
| Olmesartan-Hydrochlorothiazide | 11 | $1,058 | $96 |
| Levothyroxine | 14 | $444 | $32 |
| Clopidogrel | 11 | $373 | $34 |
| Losartan | 17 | $175 | $10 |
| Metformin Hcl Er | 11 | $105 | $10 |
| Atenolol | 18 | $70 | $4 |
| Carvedilol | 11 | $68 | $6 |
2016: 16 drugs
| Eliquis | 38 | $15,628 | $411 |
| Crestor | 19 | $12,519 | $659 |
| Xarelto | 33 | $11,768 | $357 |
| Benicar Hct | 25 | $7,985 | $319 |
| Entresto | 11 | $4,268 | $388 |
| Zontivity | 11 | $3,174 | $289 |
| Azor | 12 | $3,171 | $264 |
| Rosuvastatin | 21 | $2,096 | $100 |
| Metoprolol | 40 | $1,591 | $40 |
| Atorvastatin | 70 | $1,424 | $20 |
| Levothyroxine | 19 | $640 | $34 |
| Flecainide Acetate | 23 | $606 | $26 |
| Valsartan | 13 | $539 | $41 |
| Clopidogrel | 20 | $496 | $25 |
| Losartan | 14 | $184 | $13 |
| Atenolol | 19 | $46 | $2 |
2015: 13 drugs
| Xarelto | 42 | $15,564 | $371 |
| Crestor | 21 | $11,078 | $528 |
| Propafenone Hcl Er | 18 | $9,847 | $547 |
| Eliquis | 23 | $8,598 | $374 |
| Benicar Hct | 18 | $5,915 | $329 |
| Azor | 11 | $2,418 | $220 |
| Atorvastatin | 83 | $1,689 | $20 |
| Flecainide Acetate | 40 | $1,184 | $30 |
| Metoprolol | 20 | $831 | $42 |
| Levothyroxine | 15 | $538 | $36 |
| Clopidogrel | 17 | $305 | $18 |
| Losartan | 15 | $115 | $8 |
| Atenolol | 17 | $108 | $6 |
2014: 12 drugs
| Xarelto | 55 | $18,560 | $337 |
| Eliquis | 53 | $16,664 | $314 |
| Crestor | 35 | $13,783 | $394 |
| Propafenone Hcl Er | 30 | $11,993 | $400 |
| Metoprolol | 44 | $2,019 | $46 |
| Atorvastatin | 75 | $1,924 | $26 |
| Flecainide Acetate | 32 | $953 | $30 |
| Clopidogrel | 21 | $650 | $31 |
| Levothyroxine | 17 | $422 | $25 |
| Losartan-Hydrochlorothiazide | 15 | $258 | $17 |
| Amlodipine Besylate | 11 | $245 | $22 |
| Atenolol | 18 | $81 | $5 |
2013: 13 drugs
| Propafenone | 51 | $19,681 | $386 |
| Xarelto | 54 | $16,601 | $307 |
| Crestor | 46 | $13,970 | $304 |
| Eliquis | 41 | $12,594 | $307 |
| Brilinta | 17 | $4,631 | $272 |
| Atorvastatin | 88 | $3,124 | $35 |
| Metoprolol | 46 | $2,139 | $47 |
| Clopidogrel | 22 | $1,457 | $66 |
| Flecainide Acetate | 27 | $910 | $34 |
| Losartan-Hydrochlorothiazide | 13 | $367 | $28 |
| Amlodipine Besylate | 12 | $236 | $20 |
| Levothyroxine | 14 | $235 | $17 |
| Atenolol | 34 | $146 | $4 |
Money from drug and device companies
$1,362 in 2025
| 2025 | 10 | 35 | None | $1,362 |
| 2024 | 12 | 51 | None | $1,778 |
| 2023 | 6 | 25 | None | $998 |
| 2022 | 14 | 52 | None | $1,908 |
| 2021 | 11 | 39 | $1,343 | $2,747 |
| 2020 | 9 | 49 | $315 | $1,284 |
| 2019 | 12 | 84 | None | $2,373 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Wegovy | $313 | 6 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $221 | 4 payments
|
| Merck Sharp & Dohme | Verquvo | $200 | 7 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $184 | 4 payments
|
| Ucb | Bimzelx | $173 | 7 payments
|
| Galderma Laboratories L.P. | Nemluvio | $100 | 1 payment
|
See all 35 published payments
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-25 | Kerendia | $23 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-07 | Kerendia | $150 |
| Ucb | Meals · 2025-11-04 | Bimzelx | $15 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-28 | Kerendia | $28 |
| Bayer Healthcare Pharmaceuticals | Education · 2025-10-28 | Kerendia | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-14 | None | $132 |
| Merck Sharp & Dohme | Meals · 2025-10-06 | Capvaxive | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-25 | Eliquis | $22 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-25 | Eliquis | $5 |
| Ucb | Meals · 2025-09-23 | Bimzelx | $11 |
| Ucb | Meals · 2025-09-05 | Bimzelx | $29 |
| Novartis Pharmaceuticals | Meals · 2025-08-28 | Leqvio | $31 |
| Merck Sharp & Dohme | Meals · 2025-07-16 | Verquvo | $28 |
| Galderma Laboratories L.P. | Meals · 2025-06-26 | Nemluvio | $100 |
| Novartis Pharmaceuticals | Meals · 2025-06-25 | Leqvio | $32 |
| Boston Scientific | Meals · 2025-05-30 | Watchman Flx | $23 |
| Ucb | Meals · 2025-05-22 | Bimzelx | $38 |
| Novo Nordisk | Meals · 2025-05-19 | Wegovy | $21 |
| Merck Sharp & Dohme | Meals · 2025-05-15 | Verquvo | $30 |
| Ucb | Meals · 2025-05-01 | Bimzelx | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-30 | Camzyos | $25 |
| Novo Nordisk | Meals · 2025-04-21 | Ozempic | $123 |
| Novo Nordisk | Meals · 2025-04-17 | Wegovy | $119 |
| Merck Sharp & Dohme | Meals · 2025-04-14 | Verquvo | $30 |
| Novo Nordisk | Meals · 2025-04-07 | Wegovy | $21 |
| Ucb | Meals · 2025-03-27 | Bimzelx | $31 |
| Boston Scientific | Meals · 2025-03-20 | Watchman Flx | $27 |
| Ucb | Meals · 2025-03-19 | Bimzelx | $31 |
| Amgen | Meals · 2025-03-18 | Repatha | $30 |
| Merck Sharp & Dohme | Meals · 2025-03-11 | Verquvo | $30 |
| Novo Nordisk | Meals · 2025-03-10 | Ozempic | $15 |
| Janssen Biotech | Meals · 2025-02-21 | Tremfya | $29 |
| Merck Sharp & Dohme | Meals · 2025-02-11 | Verquvo | $26 |
| Novo Nordisk | Meals · 2025-02-06 | Ozempic | $15 |
| Merck Sharp & Dohme | Meals · 2025-01-23 | Verquvo | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,778
| Amgen | Repatha | $326 | 15 payments
|
| Novo Nordisk | Wegovy | $294 | 6 payments
|
| Merck Sharp & Dohme | Verquvo | $260 | 6 payments
|
| Novartis Pharmaceuticals | Leqvio | $249 | 8 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $236 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $118 | 1 payment
|
| Janssen Biotech | Tremfya | $87 | 3 payments
|
| Azurity Pharmaceuticals | Edarbi | $59 | 2 payments
|
| iRhythm Technologies | Zio Xt Patch | $58 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $39 | 1 payment
|
| Abbvie | Skyrizi | $27 | 1 payment
|
| Biofrontera | Ameluz | $25 | 1 payment
|
2023: $998
| Janssen Pharmaceuticals | Xarelto | $307 | 6 payments
|
| Merck Sharp & Dohme | Verquvo | $259 | 6 payments
|
| Novartis Pharmaceuticals | Leqvio | $175 | 6 payments
|
| Paratek Pharmaceuticals | Nuzyra | $127 | 2 payments
|
| Amgen | Repatha | $79 | 3 payments
|
| Alnylam Pharmaceuticals | Onpattro | $51 | 2 payments
|
2022: $1,908
| Merck Sharp & Dohme | Verquvo | $399 | 11 payments
|
| Alnylam Pharmaceuticals | Onpattro | $262 | 6 payments
|
| iRhythm Technologies | Zio Xt Patch | $220 | 5 payments
|
| Paratek Pharmaceuticals | Nuzyra | $211 | 10 payments
|
| Novo Nordisk | Ozempic | $145 | 3 payments
|
| Medtronic | Linq II | $138 | 2 payments
|
| Esperion Therapeutics | Nexlizet | $125 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $125 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $92 | 4 payments
|
| Amgen | Repatha | $87 | 4 payments
|
| Abbvie | Humira | $37 | 2 payments
|
| Kowa Pharmaceuticals America | Livalo | $25 | 1 payment
|
| Pfizer | Vyndaqel | $25 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $18 | 1 payment
|
2021: $2,747
| AstraZeneca Pharmaceuticals LP | Brilinta | $1,379 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $274 | 5 payments
|
| Novo Nordisk | Ozempic | $242 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $185 | 9 payments
|
| Pfizer | Vyndaqel | $162 | 6 payments
|
| Paratek Pharmaceuticals | Nuzyra | $131 | 2 payments
|
| Boston Scientific | Watchman | $125 | 1 payment
|
| Arbor Pharmaceuticals | Edarbi | $87 | 4 payments
|
| Amgen | Otezla | $82 | 3 payments
|
| Kowa Pharmaceuticals America | Livalo | $47 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $34 | 2 payments
|
2020: $1,284
| AbbVie | Humira | $379 | 4 payments
|
| Arbor Pharmaceuticals | Edarbi | $310 | 25 payments
|
| Janssen Pharmaceuticals | Xarelto | $212 | 5 payments
|
| Amgen | Corlanor | $110 | 4 payments
|
| Kowa Pharmaceuticals America | Livalo | $78 | 3 payments
|
| Amarin Pharma | Vascepa | $59 | 3 payments
|
| Pfizer | Vyndaqel | $55 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $43 | 2 payments
|
| Regeneron Pharmaceuticals | Dupixent | $39 | 1 payment
|
2019: $2,373
| Pfizer | Vyndaqel | $484 | 9 payments
|
| Arbor Pharmaceuticals | Edarbi | $394 | 38 payments
|
| Janssen Pharmaceuticals | Xarelto | $359 | 7 payments
|
| AbbVie | Humira | $302 | 6 payments
|
| Sanofi-Aventis U.S. | Praluent | $219 | 6 payments
|
| Novartis Pharmaceuticals | Entresto | $182 | 4 payments
|
| Dermira | Qbrexza | $150 | 1 payment
|
| Amgen | Corlanor | $117 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $101 | 5 payments
|
| Regeneron Healthcare Solutions | Praluent | $26 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $23 | 1 payment
|
| Allergan | Bystolic | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 17.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1992891493
- Licence
- CA A45961California A45961: Current · expires 2028-08-31
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A459610
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 525 South Dr Ste 105, Mountain View, CA, 94040
- NPI first listed
- 2006-10-04
- NPI last updated
- 2024-04-15
- NPI record certified
- 2024-04-15
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305